Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort.
May Yee ChoiAnn E ClarkeYvan St PierreJohn G HanlyMurray B UrowitzJuanita Romero-DiazCaroline GordonSang-Cheol BaeSasha BernatskyDaniel J WallaceJoan T MerrillDavid A IsenbergAnisur RahmanEllen M GinzlerMichelle A PetriIan N BruceMary A DooleyPaul R FortinDafna D GladmanJorge Sanchez-GuerreroKristjan SteinssonRosalind Ramsey-GoldmanMunther A KhamashtaCynthia AranowGraciela S AlarcónSusan ManziOla NivedAsad A ZomaRonald F van VollenhovenManuel Ramos-CasalsGuillermo Ruiz-IrastorzaS Sam LimKenneth C KalunianMurat InancDiane L KamenChristine A PeschkenSoren JacobsenAnca AskanaseThomas StollJill BuyonMichael MahlerMarvin J FritzlerPublished in: Arthritis care & research (2019)
In newly diagnosed systemic lupus erythematosus, 6.2% of patients were anticellular antibody negative, and 1.5% had an isolated CMP. The prevalence of anticellular antibody-negative systemic lupus erythematosus will likely decrease as emerging nomenclature guidelines recommend that non-nuclear patterns should also be reported as a positive ANA.